The prevalence of maternal cardiovascular comorbidities, disease, and complications increased from 2001 to 2019.

Results of a phase 2 trial suggest that ruxolitinib cream 1.5% may be an effective treatment option for adults with nonatopic chronic hand eczema.

The incidence of dermatologic disease among people with HIV decreased from 2011 to 2023, but it remains prevalent.

While safety is comparable between the treatments, the efficacy of PCL is superior to that of PLLA for the treatment of nasolabial fold wrinkles.

The current law, which bans abortion after 6 weeks of pregnancy, would instead start as soon as pregnancy can be medically detected.

The rate of antibiotic resistance in infections was 1 in 6 worldwide and 1 in 3 in Southeast Asia and the Eastern Mediterranean in 2023.

There were 4 outbreaks of domestic malaria comprising 10 total patients in 2023 after 20 years with no locally acquired cases.

The FDA has approved Libtayo for the adjuvant treatment of adult patients with CSCC at high risk of recurrence after surgery and radiation.

Ambient AI scribes were associated with reducing clinician administrative burden and burnout in a quality improvement study.

Child atopic dermatitis activity and severity were dose-dependently associated with maternal depression across childhood.

Improvements in survival were seen for those residing in rural and high-poverty communities in Medicaid expansion states.

Extended dosing of dupilumab in patients with AD has similar efficacy as standard dosing, with no significant affect seen on ocular adverse events.